Cansino Deferred Long Term Liab from 2010 to 2024
| 688185 Stock | 62.11 5.49 8.12% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 59.7 M | Current Value 41.5 M | Quarterly Volatility 14 M |
Check Cansino Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cansino Biologics' main balance sheet or income statement drivers, such as Net Interest Income of 27.1 M, Interest Income of 105.1 M or Interest Expense of 67.4 M, as well as many indicators such as . Cansino financial statements analysis is a perfect complement when working with Cansino Biologics Valuation or Volatility modules.
Cansino | Deferred Long Term Liab |
Currently Active Assets on Macroaxis
Other Information on Investing in Cansino Stock
Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.